SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-272546
Filing Date
2023-11-07
Accepted
2023-11-07 17:03:59
Documents
16
Period of Report
2023-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d565120d8k.htm   iXBRL 8-K 31171
2 EX-1.1 d565120dex11.htm EX-1.1 185345
3 EX-5.1 d565120dex51.htm EX-5.1 7862
7 GRAPHIC g565120dsp44a.jpg GRAPHIC 11858
8 GRAPHIC g565120dsp44b.jpg GRAPHIC 18530
  Complete submission text file 0001193125-23-272546.txt   445847

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alec-20231107.xsd EX-101.SCH 2838
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20231107_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20231107_pre.xml EX-101.PRE 11253
10 EXTRACTED XBRL INSTANCE DOCUMENT d565120d8k_htm.xml XML 3328
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 231384969
SIC: 2836 Biological Products, (No Diagnostic Substances)